Large language models as decision aids in neuro-oncology: a review of shared decision-making applications

Aaron Lawson McLean,Yonghui Wu,Anna C. Lawson McLean,Vagelis Hristidis
DOI: https://doi.org/10.1007/s00432-024-05673-x
2024-03-21
Journal of Cancer Research and Clinical Oncology
Abstract:Shared decision-making (SDM) is crucial in neuro-oncology, fostering collaborations between patients and healthcare professionals to navigate treatment options. However, the complexity of neuro-oncological conditions and the cognitive and emotional burdens on patients present significant barriers to achieving effective SDM. This discussion explores the potential of large language models (LLMs) such as OpenAI's ChatGPT and Google's Bard to overcome these barriers, offering a means to enhance patient understanding and engagement in their care. LLMs, by providing accessible, personalized information, could support but not supplant the critical insights of healthcare professionals. The hypothesis suggests that patients, better informed through LLMs, may participate more actively in their treatment choices. Integrating LLMs into neuro-oncology requires navigating ethical considerations, including safeguarding patient data and ensuring informed consent, alongside the judicious use of AI technologies. Future efforts should focus on establishing ethical guidelines, adapting healthcare workflows, promoting patient-oriented research, and developing training programs for clinicians on the use of LLMs. Continuous evaluation of LLM applications will be vital to maintain their effectiveness and alignment with patient needs. Ultimately, this exploration contends that the thoughtful integration of LLMs into SDM processes could significantly enhance patient involvement and strengthen the patient-physician relationship in neuro-oncology care.
oncology
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are the challenges faced by Shared Decision - Making (SDM) in neuro - oncology, and it explores the potential role of Large Language Models (LLMs) in overcoming these challenges. Specifically: 1. **Barriers on the patient side**: - **Limited health literacy**: Patients may have difficulty understanding complex medical terms and information, resulting in their inability to fully participate in treatment decisions. - **Emotional impact**: Patients diagnosed with neuro - tumors may be affected by emotions such as fear and anxiety, which in turn affect their communication and decision - making abilities. - **Cognitive impairment**: Brain tumors may lead to impaired cognitive function, further hindering patients' understanding and participation in the decision - making process. - **Information overload**: A large amount of information on the Internet may cause patients to feel confused and have difficulty making informed decisions. 2. **Barriers on the doctor side**: - **Time constraints**: Due to busy schedules and a large number of patients, doctors may not have enough time for in - depth discussions and shared decision - making. - **Emotional burden and burnout**: Doctors may face emotional stress and burnout when taking care of brain tumor patients, affecting their ability to participate in shared decision - making. - **Knowledge update**: The rapid development in the field of neuro - oncology makes it difficult for doctors to keep up with the latest research and treatment methods. - **Inequality in the doctor - patient relationship**: In the traditional medical model, doctors often dominate, which may lead to the neglect of patients' voices. - **Communication skills**: Doctors need to have clear and understandable communication skills to ensure that patients can understand complex information. 3. **Potential roles of LLMs**: - **Enhancing patient education**: LLMs can provide personalized information to help patients better understand their conditions and treatment options. - **Reducing information overload**: LLMs can simplify complex information into an easy - to - understand form, reducing patients' confusion. - **Supporting clinical decision - making**: LLMs can assist doctors' decision - making processes by providing evidence - based suggestions. - **Promoting patient participation**: By providing clear information, LLMs can help patients more actively participate in treatment decisions. 4. **Ethical considerations**: - **Patient privacy and informed consent**: Ensuring the security and privacy protection of patient data is crucial when using LLMs. - **Responsible use**: LLMs should be used as an auxiliary tool, not a substitute for doctors' professional judgment. - **Continuous evaluation and improvement**: Regularly evaluate the output of LLMs to ensure its accuracy and relevance. In conclusion, this paper aims to explore how to use LLMs to overcome the barriers to shared decision - making in neuro - oncology, improve patient participation and satisfaction, while emphasizing ethical and technical considerations.